Table: Brightpath Biotherapeutics - 9-MTH parent results

BrightPath Biotherapeutics Co

10/02/2022 07:00

Feb 10 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2021        Dec 31, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               1 mln             2 mln     
                 (-82.1 pct)         (-34.1 pct)       (-20.1 pct)  
  Operating       loss 1.07           loss 1.29         loss 1.85   
  Recurring       loss 1.08           loss 1.29         loss 1.85   
  Net             loss 1.08           loss 1.28         loss 1.85   
  EPS          loss 20.96 yen      loss 27.32 yen    loss 36.49 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T